| |
| Magyar Immunológiai Társaság |
|
| EMBO workshop: The inflammasomes (September 25-28, 2018., Munich, Germany) |
 Rendezvény kezdete: 2018.09.25. | Rendezvény vége: 2018.09.28. |
| Helyszín: Germany, Munich, |
| A rendezvény Web oldala: http://meetings.embo.org/event/18-inflammasomes |
Venue: Max-Planck-Institute in Martinsried (Munich
Registration Deadline: 4 June 2018
Abstract Submission Deadline: 4 June 2018
We managed to put together a fantastic speaker line-up that includes some of the top scientists in this emerging field. Sessions will cover topics ranging from molecular mechanisms of inflammasome activation, to disease models, and up to therapeutic applications. To complement these fantastic scientific topics and to encourage networking, a range of social events will be held, including "Meet-the-PI" and a "Bavarian Night". Further information regarding program, prices and registration can be found in the attached poster and on our website: http://meetings.embo.org/event/18-inflammasomes >>
|
|
|
 |
| |
| Magyar Kardiológusok Társasága |
|
| International Conference on Early Disease Detection and Prevention (EDDP) |
| Rendezvény kezdete: 2010.02.25. | Rendezvény vége: 2010.02.28. |
| Helyszín: Németország, München, |
| A rendezvény Web oldala: http://www.paragon-conventions.com/EDDP2010 |
This year's EDDP conference will focus on cardiovascular (cardiac disease and hypertension), metabolic (diabetes) and renal diseases. With a scientific program featuring a distinguished international panel of leading speakers, as well as a concurrent exhibition, this conference aims to:
Discuss all elements relevant to early detection of disease prior to its clinical appearance
Highlight the most updated technological and other means for disease prevention
Encourage a free exchange of ideas among high-caliber presenters and participants
Serve as a platform for the biotech/pharma industries to discuss ongoing projects and products
Present general principles, ongoing academic/industrial research, and the latest achievements in the field
Highlight biotechnological innovations and evaluate their applicability and cost-effectiveness
Set the stage for prevention of disease by pharmacological, genetic or other interventional modalities |
|
|
|
